fbpx

Pier 1 Imports (PIR) Securities Fraud Class Action Lawsuit

This securities fraud lawsuit alleges that executives at Pier 1 Imports systemically understated the cost to move into online retail channels and systemically overstated forecasted future revenues.  Read more

Biogen (BIIB) TECFIDERA Securities Fraud Class Action Lawsuit

This lawsuit alleges that, during the first half of 2015, Biogen purposefully overstated its future revenue growth, based largely on expectations for its flagship drug TECFIDERA, and that the overstated forecast artificially inflated the Biogen stock price.  Read more

Plains All American Pipeline (PAA) Securities Fraud Class Action

This securities fraud class action alleges that Plains All American Pipeline issued false and misleading statements concerning its pipeline monitoring, maintenance and spill response measures, as well as its compliance with federal regulations governing its pipeline operations.  Read more

Resource Capital (RSO) Securities Fraud Class Action Lawsuit

This securities fraud class action alleges that Resource Capital should have disclosed its exposure to the Puerto Rican economy sooner than it did and therefore the REIT was trading at an artificially inflated value.  Read more

Abengoa (ABGB) Securities Fraud Class action Lawsuit

This lawsuit alleges that since November 12, 2014, Abengoa has misrepresented the liquidity of  its balance sheet in corporate reports filed with the SEC and in conference calls with financial analysts.   Read more

Trinet Group (TNET) Securities Fraud Class Action Lawsuit

This lawsuit alleges Trinet misrepresented to investors the accurate costs associated with workers compensation claims.  Specifically, that the company was experiencing greater than announced worker compensation costs even after analysts queried executives about the lower-than-industry average cost projections.  Read more

Northwest Biotherapuetics (NWBO) Securities Fraud Class Action Lawsuit

This securities class action alleges that executives at Northwest Biotherapeutics overstated or misstated results from ongoing clinical trials of certain therapies and engaged in an undisclosed stock promotion campaign to artificially inflate the company's stock price.  Read more

El Pollo Loco (LOCO) Securities Fraud Class Action Suit

This lawsuit alleges that executives at El Pollo Loco hid from investors the negative impact of rising labor and food costs and the decrease in same store traffic so that insiders could sell millions of dollars of stock at artificially inflated prices.  Read more

CaesarStone (CSTE) Securities Fraud CLass Action Lawsuit

     This securities fraud class action alleges that CaesarStone  failed to disclose a whole series of negative news developments to investors in real time and in fact purposely kept the news from them.  Read more

ConforMIS (CFMS) Securities Fraud Class Action Lawsuit

     This securities fraud class action alleges that ConforMIS knew of manufacturing problems relating to its joint replacement devices during its IPO and immediately thereafter but failed to warn investors. Less than two months after its IPO, ConforMIS announced that it was recalling 950 joint replacement devices (650 of which had already been used  Read more